Center for Global Research Data
Our Members
Paratek Pharmaceuticals, Inc.
| About | Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use.
The company’s lead commercial product, NUZYRA® (omadacycline), is a once-daily oral and intravenous antibiotic available in the United States for the treatment of adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). |
| How we share on the AMR Register | To obtain Paratek’s AMR surveillance data for analysis, researchers should use the AMR Register platform to submit a request. The anonymized data will then be made available to the researcher to download. Data for ongoing surveillance programs will be updated annually. |
| Programs Listed for Sharing | Paratek’s AMR surveillance data available on the AMR Register: • KEYSTONE – Omadacycline |
| What information will be provided | Where available, the following data and information is provided for each dataset:
🗹 Raw dataset. This is the dataset containing the anonymized isolate level data collected during the study. The dataset can be downloaded. 🗹 Program description. Information about how the data were collected are provided on the program pages. 🗹 Links to Publications. Links to journal publications based on the data collected are provided on the program pages. |
| Questions or enquiries | Please send any questions or enquiries to amr@vivli.org |
| Paratek’s Register or Website | http://paratek-keystone.com |